Compound: MK-2206

Drug Target: AKT1, AKT2

Drug Target pathway: PI3K/MTOR signaling

Dataset



Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.